Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
California Nanotechnologies Corp (CANOF) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of California Nanotechnologies Corp $0.41, price $0.29, upside +41.4%, quality 27 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? No
- Add to watchlist
CN
Thin data
Sep 24, 2026
Thin data
Sep 24, 2026
California Nanotechnologies Corp
CANOF · USSpeculativeUpside exists, but weak quality makes the signal speculative.
✓Fair value $0.4100 · Undervalued (+41.4%)
!Quality 27/100
!Expensive Growth (revenue 5y +52.7 %/yr)
!Loss-making · -70.7% net margin (TTM)
✓Low debt · generates free cash flow
!Narrow moat 15/100
!Evidence only low, so the estimate is less certain
Watch California Nanotechnologies Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.0484 – $1.40 · fair‑value band $0.2200 – $0.6700 · the $0.2900 price screens below the $0.4100 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Company profile
California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction.
Show more
California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction. The company offers sintering, bonding, and hot isostatic pressing services, including spark plasma/field assisted sintering, hot pressing/direct hot pressing, high temp sintering, diffusion bonding, and vacuum/pressure-less sintering; cryo milling/particle reduction/grinding comprising cryogenic milling and grinding, planetary ball milling, mechanical alloying, inert gas milling, pulverizing, and mechanical alloying services; and material development/testing, such as composites/nano-composites, mechanical testing and analysis, sample fabrication, prototyping, SEM analysis, and particle size analysis, as well as coating targets/sputter targets. It also provides tooling and consumables, which consists of high strength SPS graphite tooling, tungsten carbide tooling, carbon graphite foil/paper, and carbon felt and yarn, as well as spark plasma sintering systems and SPS/FAST modeling software. The company serves defense and aerospace, energy and nuclear, electronics and semiconductors, sustainable technologies, and research and development industries. California Nanotechnologies Corp. is headquartered in Cerritos, California.
Stock analysis
California Nanotechnologies Corp (CANOF) currently trades at $0.2900, while our model-based Fair Value estimate is $0.4100, implying the stock looks roughly 29.3% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $0.4200 per share, and 6 of the 13 models we run sit above the $0.2900 price.
Bear case: the Earnings-Based group reads lowest at $0.0900, and 7 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.2200 (bear) to $0.6700 (bull), the price of $0.2900 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 27/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
California Nanotechnologies Corp reported revenue of $6.2M in FY2025 versus $831K in FY2021, a compound +65.4%/yr. Reported net income was −$158K in FY2025.
Key figures
Market cap $13.1M · P/S ratio 2.70 · EPS (TTM) $−0.0400 · Net margin −2.5% · Return on equity −110% · Return on assets (EBIT) 13.2% · Operating margin −211% · Revenue (TTM) $3.0M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 32% below its 52-week high and 104% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −46% fair-value upside, at 41%, CANOF screens cheaper than that median.
Fair Value models
Bear $0.2200
Fair Value $0.4100
Bull $0.6700
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV
$0.0800
$0.0900
$0.1100
74
FCF DCF
$0.3000
$0.4700
$0.9900
73
Growth DCF
$0.2800
$0.5500
$0.9700
73
All 13 models by family
DCF Models
FCF DCF
$0.3000
$0.4700
$0.9900
73
5Y Revenue Exit
$0.1800
$0.2900
$0.5200
68
5Y EBITDA Exit
$0.2200
$0.3800
$0.6900
70
10Y Revenue Exit
$0.2100
$0.4200
$0.5400
64
10Y EBITDA Exit
$0.2500
$0.5200
$0.9700
63
Earnings-Based
EPV
$0.0800
$0.0900
$0.1100
74
Multiples
EV/EBIT
$0.1300
$0.1800
$0.2200
66
EV/EBITDA
$0.1800
$0.2400
$0.3100
67
EV/Revenue
$0.1100
$0.1600
$0.2100
53
Asset-Based
NCAV (Graham)
$0.0200
$0.0300
$0.0500
52
Growth DCF
Growth DCF
$0.2800
$0.5500
$0.9700
73
Rev-Margin DCF
$0.1900
$0.3300
$0.6200
67
Economic Profit
ROIC Compounder
$0.1100
$0.1600
$0.2000
69
Notify me when CANOF reaches fair value
Put CANOF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
27/100
Of which business quality 37 · Market factors (momentum, volatility) 41
Profitability
39
Margins and returns on capital today
Quality Growth
40
Are margins and returns improving?
Cashflow
53
Earnings quality: real cash, not paper profit
Fin. Strength
60
Balance sheet, leverage, solvency risk
Investment
0
Disciplined investing over empire-building
Low Volatility
25
Calm price path (market factor)
Momentum
48
Price trend over the last 3–12 months (market factor)
52W Momentum
47
Distance to the 52-week high (market factor)
Net Issuance
0
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
61/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+86.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+98.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.7%
Start year 2020 (pandemic). Over 10 years: +33.3% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.7% (2019) → 19.0% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +6.5% a year for the price.
Watch CANOF, get fair value alerts →
Compare California Nanotechnologies Corp with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 696 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
Context: sector, industry, market
- Is the Materials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $474.65 | $441.72 | −7% |
| The Sherwin-Williams Company SHW | $330.44 | $151.68 | −54% |
| Ecolab Inc ECL | $274.58 | $96.56 | −65% |
| Air Products and Chemicals, Inc APD | $279.19 | $121.30 | −57% |
| Nan Ya Plastics Corporation 1303 | 238.00 TWD | 234.23 TWD | −2% |
| Givaudan SA GIVN | CHF 3,360 | CHF 1,527 | −55% |
| Sika AG SIKA | CHF 183.80 | CHF 98.89 | −46% |
| Wanhua Chemical Group 600309 | ¥69.45 | ¥68.03 | −2% |
| DSM-Firmenich AG DSFIR | CHF 92.30 | CHF 29.70 | −68% |
| Asian Paints Limited ASIANPAINT | ₹2,444 | ₹1,479 | −39% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is California Nanotechnologies Corp (CANOF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.4100 versus a price of $0.2900, about +41% upside (undervalued).
What is the fair value of CANOF?
Our model-based fair value for California Nanotechnologies Corp is $0.4100 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.2900.
What is the quality score of CANOF?
California Nanotechnologies Corp has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for California Nanotechnologies Corp (CANOF)?
Our model-based price target is the fair value of $0.4100 (as of Sep 24, 2026) from 13 valuation models. Cautious scenario $0.2200, optimistic scenario $0.6700. It is a calculation from audited fundamentals, not an analyst target.
What is the California Nanotechnologies Corp stock forecast for 2026?
Our models put fair value at $0.4100, about +41% upside versus a price of $0.2900 (undervalued). Cautious scenario $0.2200, optimistic scenario $0.6700. The calculation is refreshed regularly with new filings.
What is the revenue of California Nanotechnologies Corp (CANOF)?
California Nanotechnologies Corp reported trailing-twelve-month revenue of about $3.0M (latest available figure, as of Sep 24, 2026).
What growth is priced into California Nanotechnologies Corp (CANOF)?
For today's price to be fair in a discounted-cash-flow model, California Nanotechnologies Corp would have to grow free cash flow by +9.0 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +52.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of CANOF use?
Our models discount California Nanotechnologies Corp at 10.1 %: a base by market capitalisation (nano), damped by beta 1.15, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For California Nanotechnologies Corp that is +9.0 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has California Nanotechnologies Corp (CANOF) delivered so far?
Over the past 5 years revenue at California Nanotechnologies Corp grew +52.7 % a year. The price currently implies +9.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of California Nanotechnologies Corp (CANOF) growing?
The median revenue growth in the sector is +7.6 % a year. That is the yardstick for the growth priced into California Nanotechnologies Corp (+9.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of California Nanotechnologies Corp (CANOF)?
The free-cash-flow yield on the price is 6.10 %: that much free cash flow California Nanotechnologies Corp produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of California Nanotechnologies Corp (CANOF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For California Nanotechnologies Corp it is $0.4100 per share (as of Sep 24, 2026), against a price of $0.2900. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is California Nanotechnologies Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CANOF trades below its calculated fair value: price $0.2900, fair value $0.4100, a gap of about +41% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CANOF?
No. The price is what the market pays today ($0.2900); the fair value is what the company's own numbers justify ($0.4100). For California Nanotechnologies Corp the two are $0.1200 per share apart. That gap is exactly why we show both numbers side by side.
How much is California Nanotechnologies Corp worth?
The market values California Nanotechnologies Corp at about $13.1M (market capitalisation, as of Sep 24, 2026). Per share that is $0.2900; our models calculate a fair value of $0.4100 per share.
What do the bullish and bearish scenarios say about CANOF?
Our models span a range for California Nanotechnologies Corp: cautious scenario $0.2200, base $0.4100, optimistic $0.6700 per share (as of Sep 24, 2026, price $0.2900). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of California Nanotechnologies Corp (CANOF)?
Balance-sheet figures for California Nanotechnologies Corp (as of Sep 24, 2026): return on equity −110.2%, debt of 0.42 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is CANOF from its 52-week high?
California Nanotechnologies Corp trades at $0.2900, about 32% below its 52-week high of $0.4282 and 104% above the low of $0.1425 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4100 is for.
Which stocks are comparable to California Nanotechnologies Corp?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is California Nanotechnologies Corp stock attractive at the current price?
The data as of Sep 24, 2026: price $0.2900, calculated fair value $0.4100 (+41%), Quality Score 27/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CANOF calculated?
We run California Nanotechnologies Corp through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.4100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. California Nanotechnologies Corp currently trades 29 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of California Nanotechnologies Corp (CANOF)?
The closing price on Oct 2, 2026 was $0.2900. Our model-based fair value is $0.4100, about +41% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with California Nanotechnologies Corp right now?
The large discount to fair value meets weak quality (27/100). That raises the risk this is a value trap rather than a bargain. The model range is unusually wide ($0.2200 to $0.6700). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of California Nanotechnologies Corp
How large is the market capitalisation of California Nanotechnologies Corp (CANOF)?
The market capitalisation of California Nanotechnologies Corp is $13.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of California Nanotechnologies Corp (CANOF)?
The price-to-sales ratio of California Nanotechnologies Corp is 2.70 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of California Nanotechnologies Corp (CANOF)?
Earnings per share at California Nanotechnologies Corp are $−0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of California Nanotechnologies Corp (CANOF)?
The net margin of California Nanotechnologies Corp is −2.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of California Nanotechnologies Corp (CANOF)?
The return on equity (ROE) of California Nanotechnologies Corp is −110% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of California Nanotechnologies Corp (CANOF)?
On an EBIT basis the return on assets of California Nanotechnologies Corp is 13.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of California Nanotechnologies Corp (CANOF)?
The operating margin of California Nanotechnologies Corp is −211% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at California Nanotechnologies Corp (CANOF)?
Revenue at California Nanotechnologies Corp is growing −78.3% versus a year earlier (3y avg +98.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at California Nanotechnologies Corp (CANOF)?
Earnings per share at California Nanotechnologies Corp are growing −78.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does California Nanotechnologies Corp (CANOF) carry?
The net debt of California Nanotechnologies Corp is $1.1M (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch California Nanotechnologies Corp in the live analysis
One click puts California Nanotechnologies Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.